Clinical Trial Update: Atorvastatin for HAART Suboptimal Responders [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atorvastatin for HIV patients on HAART who are suboptimal responders; completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Makerere University | Conditions: Acquired Immune Deficiency Syndrome Virus | Phase 3 | Status: COMPLETED | Results posted: 2015-05-21